Evidence map›Paper›PMID 22915642›Full record

ArticleBlood2012

Microfluidic kit-on-a-lid: a versatile platform for neutrophil chemotaxis assays.

Eric K Sackmann, Erwin Berthier, Edmond W K Young, Miriam A Shelef, Sarah A Wernimont, Anna Huttenlocher, David J Beebe

Registry-linked trialAbstract read
In one paragraph

Article in Blood, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02411318 (Influence of Lifestyle Factors on Neutrophil Migration Pilot Study), which is not on this map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02411318 nacompletednot on this mapstarted 2014, after this paper: background citation

Influence of Lifestyle Factors on Neutrophil Migration Pilot Study

TypeinterventionalSponsorUniversity of Wisconsin, MadisonRan2014 to 2019Enrolled47ConditionsNeutrophil Chemotactic ResponseArmsExercise, ProLab 200mg caffeine capsule, Ethanol ingestion, Glucose Tolerance Drink
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. [Inertial label-free sorting and chemotaxis of polymorphonuclear neutrophil in sepsis patients based on microfluidic technology].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Microfluidic devices for neutrophil chemotaxis studies.Journal of translational medicine · 2020
    Review
  12. Article
  13. Review
  14. Article
  15. MBiosensors & bioelectronics · 2018
    Article
  16. Article
  17. Neutrophil Chemotaxis in One Droplet of Blood Using Microfluidic Assays.Methods in molecular biology (Clifton, N.J.) · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Eric K SackmannMaterials Science Program, Wisconsin Institute for Medical Research, Madison, WI 53705, USA.
Erwin Berthier
Edmond W K Young
Miriam A Shelef
Sarah A Wernimont
Anna Huttenlocher
David J Beebe
Institute for Medical Research · USUniversity of Wisconsin–Madison · USMaterials Science & Engineering · AUWisconsin Institutes for Discovery · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Christian Capitini · 1985 to 2026
$142.6M
INTEGRATED TRAINING FOR PHYSICIAN-SCIENTISTST32GM008692 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BURKARD, MARK E · 1998 to 2020
$10.3M
RESEARCH TRAINING IN HEMATOLOGYT32HL007899 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Jane Ellen Churpek · 1998 to 2026
$8.2M
Understanding cell migration through microscale in vitro modelsR01EB010039 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, HUTTENLOCHER, ANNA · 2011 to 2014
$1.7M
Enabling NF-kB Signal Transduction Studies in Primary Multiple Myeloma CellsR01CA155192 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, MIYAMOTO, SHIGEKI · 2012 to 2016
$1.4M
NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA155192NHLBI NIH HHS T32 HL007899NIBIB NIH HHS R01 EB010039NIGMS NIH HHS T32 GM008692
6 · The paper itself

Abstract

Improvements in neutrophil chemotaxis assays have advanced our understanding of the mechanisms of neutrophil recruitment; however, traditional methods limit biologic inquiry in important areas. We report a microfluidic technology that enables neutrophil purification and chemotaxis on-chip within minutes, using nanoliters of whole blood, and only requires a micropipette to operate. The low sample volume requirements and novel lid-based method for initiating the gradient of chemoattractant enabled the measurement of human neutrophil migration on a cell monolayer to probe the adherent and migratory states of neutrophils under inflammatory conditions; mouse neutrophil chemotaxis without sacrificing the animal; and both 2D and 3D neutrophil chemotaxis. First, the neutrophil chemotaxis on endothelial cells revealed 2 distinct neutrophil phenotypes, showing that endothelial cell-neutrophil interactions influence neutrophil chemotactic behavior. Second, we validated the mouse neutrophil chemotaxis assay by comparing the adhesion and chemotaxis of neutrophils from chronically inflamed and wild-type mice; we observed significantly higher neutrophil adhesion in blood obtained from chronically inflamed mice. Third, we show that 2D and 3D neutrophil chemotaxis can be directly compared using our technique. These methods allow for new avenues of research while reducing the complexity, time, and sample volume requirements to perform neutrophil chemotaxis assays.

Indexed as

Cell Migration Assays, LeukocyteMicrofluidicsAnimalsArthritis, ExperimentalCell MovementCells, CulturedChemotaxis, LeukocyteHumansHuman Umbilical Vein Endothelial CellsMiceNeutrophils

Identifiers

PMID22915642
PMCPMC3466974
OpenAlexW1967150169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.